| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035617051 |
| P356 | DOI | 10.1186/S12943-015-0306-4 |
| P932 | PMC publication ID | 4339430 |
| P698 | PubMed publication ID | 25744065 |
| P5875 | ResearchGate publication ID | 272364743 |
| P2093 | author name string | Peeyush K Lala | |
| Mousumi Majumder | |||
| Xiping Xin | |||
| Elena Tutunea-Fatan | |||
| P2860 | cites work | Involvement of chemokine receptors in breast cancer metastasis | Q24290909 |
| Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13 | Q24319684 | ||
| COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer | Q24651871 | ||
| Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer | Q81709785 | ||
| [Role of CCL21/CCR7 in invasion of colorectal carcinoma cell line SW480] | Q84276512 | ||
| Clinical significance of vascular endothelial growth factors C and D and chemokine receptor CCR7 in gastric cancer | Q84586867 | ||
| VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics | Q84621185 | ||
| Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR. | Q40399380 | ||
| Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels | Q40414498 | ||
| PGE2-mediated upregulation of iNOS in murine breast cancer cells through the activation of EP4 receptors. | Q40611334 | ||
| Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis | Q40789590 | ||
| Measuring single-cell cytosolic Ca2+ concentration in response to proteoglycans | Q40792959 | ||
| CC chemokine receptor-3 undergoes prolonged ligand-induced internalization | Q40959278 | ||
| Effect of CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human pancreatic ductal adenocarcinoma | Q42149105 | ||
| Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells. | Q42450323 | ||
| Chemotrap-1: an engineered soluble receptor that blocks chemokine-induced migration of metastatic cancer cells in vivo | Q42590931 | ||
| Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. | Q44370178 | ||
| Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy | Q46684018 | ||
| Cyclooxygenase-2 up-regulates CCR7 expression via AKT-mediated phosphorylation and activation of Sp1 in breast cancer cells. | Q46782214 | ||
| Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer | Q48575675 | ||
| Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth | Q56825474 | ||
| Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis | Q57382204 | ||
| The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis | Q59387633 | ||
| Chemokine-mediated migration of melanoma cells towards lymphatics--a mechanism contributing to metastasis | Q79387215 | ||
| CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer | Q81098644 | ||
| Immunomodulatory roles of lymphatic vessels in cancer progression | Q27000429 | ||
| Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis | Q28200101 | ||
| Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma | Q28205337 | ||
| Identification and characterization of a novel beta chemokine containing six conserved cysteines | Q28246202 | ||
| Cancer and the chemokine network | Q28269751 | ||
| Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling | Q28305764 | ||
| Chemokines as mediators of neovascularization | Q30438032 | ||
| CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. | Q33201297 | ||
| Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis | Q33751824 | ||
| CCL21 Cancer Immunotherapy | Q33820300 | ||
| CCL21/CCR7 promotes G2/M phase progression via the ERK pathway in human non-small cell lung cancer cells | Q33940793 | ||
| Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer | Q34128977 | ||
| CCL21/CCR7 prevents apoptosis via the ERK pathway in human non-small cell lung cancer cells | Q34206158 | ||
| Co-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN. | Q34251088 | ||
| Lymphangiogenesis and cancer | Q36137692 | ||
| Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells. | Q36611431 | ||
| Tuning inflammation and immunity by chemokine sequestration: decoys and more | Q36662451 | ||
| A key role for CCR7 in establishing central and peripheral tolerance | Q36803195 | ||
| Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer | Q36828493 | ||
| Organ selectivity in metastasis: regulation by chemokines and their receptors | Q36949936 | ||
| Lymphangiogenesis: in vitro and in vivo models | Q37591047 | ||
| Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy | Q37772365 | ||
| Role of lymphatic vessels in tumor immunity: passive conduits or active participants? | Q37787865 | ||
| Chemokines as targets for therapy | Q37849900 | ||
| Biological basis of therapeutic lymphangiogenesis. | Q37858861 | ||
| Lymphangiogenesis and lymphatic vessel remodelling in cancer | Q38190359 | ||
| A practical and sensitive method of quantitating lymphangiogenesis in vivo | Q39146947 | ||
| Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model | Q39340968 | ||
| The chemotactic interaction between CCL21 and its receptor, CCR7, facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis | Q39540035 | ||
| Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer. | Q39683398 | ||
| Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. | Q39722616 | ||
| Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck | Q39823803 | ||
| Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype | Q39899648 | ||
| Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells. | Q40005941 | ||
| Expression patterns of lymphangiogenic and angiogenic factors in a model of breast ductal carcinoma in situ | Q40067837 | ||
| Expression and function of the chemokine receptor CCR7 in thyroid carcinomas. | Q40215535 | ||
| Generation and characterization of a mouse lymphatic endothelial cell line. | Q40305468 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | lymphangiogenesis | Q6708231 |
| P304 | page(s) | 35 | |
| P577 | publication date | 2015-02-10 | |
| P1433 | published in | Molecular Cancer | Q15724585 |
| P1476 | title | The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis | |
| P478 | volume | 14 |
| Q57106000 | Alterations of Signaling Pathways Related to the Immune System in Breast Cancer: New Perspectives in Patient Management |
| Q36370199 | CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1. |
| Q33788042 | CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer |
| Q37392868 | CCL5 promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-507 in human chondrosarcoma cells |
| Q42409232 | CCR7 Maintains Nonresolving Lymph Node and Adipose Inflammation in Obesity |
| Q33679655 | CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway. |
| Q41439903 | CCR7 promote lymph node metastasis via regulating VEGF-C/D-R3 pathway in lung adenocarcinoma |
| Q55667705 | CCR7 regulates ANO6 to promote migration of pancreatic ductal adenocarcinoma cells via the ERK signaling pathway. |
| Q33593895 | Chemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma |
| Q52723037 | Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma. |
| Q51472977 | Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors. |
| Q49634148 | Chemokines in homeostasis and diseases |
| Q64963036 | Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification. |
| Q38778516 | Construction of specific magnetic resonance imaging/optical dual-modality molecular probe used for imaging angiogenesis of gastric cancer |
| Q42293590 | ELM: A New, Simple, and Economic Assay to Measure Motility of Lymphatic Endothelial Cells |
| Q37116507 | Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy. |
| Q90115310 | Expression pattern of CDK12 protein in gastric cancer and its positive correlation with CD8+ cell density and CCL12 expression |
| Q35980816 | G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis |
| Q59136348 | Hypoxia Modifies the Transcriptome of Human NK Cells, Modulates Their Immunoregulatory Profile, and Influences NK Cell Subset Migration |
| Q90484486 | Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database |
| Q99590808 | Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma |
| Q92358706 | Inhibition of Tumor Lymphangiogenesis is an Important Part that EGFR-TKIs Play in the Treatment of NSCLC |
| Q91586391 | Matrine induces apoptosis via targeting CCR7 and enhances the effect of anticancer drugs in non-small cell lung cancer in vitro |
| Q64099517 | Meta-analysis of the prognostic value of C-C chemokine receptor type 7 in patients with solid tumors |
| Q90289909 | MicroRNA-532-3p Suppresses Malignant Behaviors of Tongue Squamous Cell Carcinoma via Regulating CCR7 |
| Q91657950 | Mir526b and Mir655 Promote Tumour Associated Angiogenesis and Lymphangiogenesis in Breast Cancer |
| Q36241115 | PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells |
| Q37124521 | Peri-articular lymphatic system and "Bi" theory of Chinese medicine in the pathogenesis and treatment of arthritis |
| Q64277308 | Prognostic value of immunoexpression of CCR4, CCR5, CCR7 and CXCR4 in squamous cell carcinoma of tongue and floor of the mouth |
| Q49887925 | Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges |
| Q37738074 | Role of tumor microenvironment in tumorigenesis |
| Q36375142 | Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC |
| Q38992680 | Stromal contributions to the carcinogenic process |
| Q28076945 | The dual role of tumor lymphatic vessels in dissemination of metastases and immune response development |
| Q33761936 | Tumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization |
| Q36183239 | miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7. |
Search more.